M&A
Olon Continues its Growth Path and Announces a New Acquistion
Olon
PR-09-24-NI-01Sep 04, 2024
Outsourced Manufacturing
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
April Stanley, MS MBA
Nice Insight
PAO-03-24-NI-02Mar 27, 2024
High Potency API Suite
Expanding Capabilities for Clients:Olon to Open New High Potency API Suite in US
Olon
PR-M02-24-01Feb 05, 2024
API
Enhanced Solubility through API Processing: Salt and Cocrystal Formation
Thomas Briel, Ph.D.; David Luedeker, Ph.D.
MilliporeSigma
PAO-05-23-CL-04May 05, 2023
Olon, International API Supplier, Releases New 2022 Sustainability Report
Olon
PR-M11-22-08Nov 22, 2022
New Facility
Piramal Pharma Solutions Holds Grand Opening Ceremony for New API Plant at Aurora, Canada Manufacturing Site
Piramal Pharma Solutions
PR-M07-22-04Jul 13, 2022
Manufacturing
The Evolving Technology Supporting API Manufacturing
Pharma's Almanac
PAO-04-22-R250-76May 03, 2022
Specialty Chemicals
Looking at the Future of U.S. API Manufacturing
Brian Graves
W.R. Grace
PAO-04-22-R250-02Apr 01, 2022
Italian CDMOs
Keeping Pharma Manufacturing Alive in Italy during COVID-19
Nice Insight
PAO-04-22-R221-64Apr 29, 2021
API Manufacturing
Piramal Pharma Solutions Invests $25 Million CAD to Expand its Aurora, Canada Facility with a State-of-the-Art API Manufacturing Wing
Piramal Pharma Ltd.
PR-M01-20-NI-038Jan 28, 2020
FDA Approval
Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins
Grifols
PR-M08-18-NI-123Aug 16, 2018
API Manufacturing
Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network
Cambrex
PR-M07-18-NI-082Jul 25, 2018
API Manufacturing
BioVectra and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion
BIOVECTRA
PR-M12-17-NI-013Dec 15, 2017
Drug Development
Harmonizing Development Internationally
Trishul Shah
PolyPeptide Group
PTV-M06-17-BIO-012Aug 23, 2017